These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26792017)

  • 1. Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges.
    Kaialy W; Al Shafiee M
    Adv Colloid Interface Sci; 2016 Feb; 228():71-91. PubMed ID: 26792017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.
    Buse J; El-Aneed A
    Nanomedicine (Lond); 2010 Oct; 5(8):1237-60. PubMed ID: 21039200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantages of nanotechnology-based Chinese herb drugs on biological activities.
    Huang S; Chang WH
    Curr Drug Metab; 2009 Oct; 10(8):905-13. PubMed ID: 20214585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and isolation of pharmaceutical drug nanoparticles.
    Verma V; Ryan KM; Padrela L
    Int J Pharm; 2021 Jun; 603():120708. PubMed ID: 33992712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.
    Ungaro F; d'Angelo I; Miro A; La Rotonda MI; Quaglia F
    J Pharm Pharmacol; 2012 Sep; 64(9):1217-35. PubMed ID: 22881435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling drug nanoparticle formation by rapid precipitation.
    D'Addio SM; Prud'homme RK
    Adv Drug Deliv Rev; 2011 May; 63(6):417-26. PubMed ID: 21565233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery.
    Iqbal HMN; Rodriguez AMV; Khandia R; Munjal A; Dhama K
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):86-93. PubMed ID: 27978790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advancements in mechanical reduction methods: particulate systems.
    Leleux J; Williams RO
    Drug Dev Ind Pharm; 2014 Mar; 40(3):289-300. PubMed ID: 23988193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formalism of fractal aggregation phenomena of colloidal drug delivery systems.
    Pippa N; Demetzos C; Danezis E
    J Liposome Res; 2012 Mar; 22(1):55-61. PubMed ID: 21774618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems.
    Keck CM; Müller RH
    Eur J Pharm Biopharm; 2013 Aug; 84(3):445-8. PubMed ID: 23333302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles.
    Wais U; Jackson AW; He T; Zhang H
    Nanoscale; 2016 Jan; 8(4):1746-69. PubMed ID: 26731460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrin based nanosponges for pharmaceutical use: a review.
    Tejashri G; Amrita B; Darshana J
    Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
    Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
    Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges to macromolecular drug delivery.
    Juliano R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of dissolution and antioxidant activity of kaempferol using a nanoparticle engineering process.
    Tzeng CW; Yen FL; Wu TH; Ko HH; Lee CW; Tzeng WS; Lin CC
    J Agric Food Chem; 2011 May; 59(9):5073-80. PubMed ID: 21417334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particle engineering principles and technologies for pharmaceutical biologics.
    Cun D; Zhang C; Bera H; Yang M
    Adv Drug Deliv Rev; 2021 Jul; 174():140-167. PubMed ID: 33845039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.